MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo

EBV persistence without its EBNA3A and 3C oncogenes in vivo

(2018) Anita Murer et al.   PLoS Pathogens

Human immunity against EBV—lessons from the clinic

(2017) Stuart G. Tangye et al.   JOURNAL OF EXPERIMENTAL MEDICINE

MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity

(2017) Manuel Albanese et al.   JOURNAL OF VIROLOGY

The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis

(2017) Brigid Chiyoko Poling et al.   VIROLOGY

The Epstein-Barr virus miR-BHRF1-1 targets RNF4 during productive infection to promote the accumulation of SUMO conjugates and the release of infectious virus

(2017) Jinlin Li et al.   PLoS Pathogens

Epstein-Barr viral miRNAs inhibit antiviral CD4 + T cell responses targeting IL-12 and peptide processing

(2016) Takanobu Tagawa et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8+T cells

(2016) Manuel Albanese et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?

(2016) Jennifer Totonchy et al.   Current Opinion in Virology

The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells

(2016) Anna M. Gram et al.   PLoS Pathogens

A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog

(2016) Katharina Bernhardt et al.   PLoS Pathogens

The Immunology of Epstein-Barr Virus–Induced Disease

(2015) Graham S. Taylor et al.   Annual Review of Immunology

Role of the 2B4 Receptor in CD8+T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System Components

(2015) Obinna Chijioke et al.   JOURNAL OF INFECTIOUS DISEASES

Epstein-Barr Viruses (EBVs) Deficient in EBV-Encoded RNAs Have Higher Levels of Latent Membrane Protein 2 RNA Expression in Lymphoblastoid Cell Lines and Efficiently Establish Persistent Infections in Humanized Mice

(2015) Goran Gregorovic et al.   JOURNAL OF VIROLOGY

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis

(2014) Shi-Dong Ma et al.   JOURNAL OF CLINICAL INVESTIGATION

Adoptive Transfer of EBV Specific CD8+ T Cell Clones Can Transiently Control EBV Infection in Humanized Mice

(2014) Olga Antsiferova et al.   PLoS Pathogens

Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling

(2014) Michiel van Gent et al.   PLoS Pathogens

Cooperation between Epstein-Barr Virus Immune Evasion Proteins Spreads Protection from CD8+ T Cell Recognition across All Three Phases of the Lytic Cycle

(2014) Laura L. Quinn et al.   PLoS Pathogens

Gammaherpesviruses and Lymphoproliferative Disorders

(2013) Ethel Cesarman   Annual Review of Pathology-Mechanisms of Disease

EBV BILF1 Evolved To Downregulate Cell Surface Display of a Wide Range of HLA Class I Molecules through Their Cytoplasmic Tail

(2013) B. D. Griffin et al.   JOURNAL OF IMMUNOLOGY

A Cluster of Virus-Encoded MicroRNAs Accelerates Acute Systemic Epstein-Barr Virus Infection but Does Not Significantly Enhance Virus-Induced Oncogenesis In Vivo

(2013) A. Wahl et al.   JOURNAL OF VIROLOGY

Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection

(2013) Obinna Chijioke et al.   Cell Reports

The Members of an Epstein-Barr Virus MicroRNA Cluster Cooperate To Transform B Lymphocytes

(2011) R. Feederle et al.   JOURNAL OF VIROLOGY

Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention

(2011) J. I. Cohen et al.   Science Translational Medicine

A Viral microRNA Cluster Strongly Potentiates the Transforming Properties of a Human Herpesvirus

(2011) Regina Feederle et al.   PLoS Pathogens

EBV Lytic-Phase Protein BGLF5 Contributes to TLR9 Downregulation during Productive Infection

(2010) M. van Gent et al.   JOURNAL OF IMMUNOLOGY

Epstein–Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-β

(2010) Gretchen L. Bentz et al.   VIROLOGY

Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells

(2010) Eri Seto et al.   PLoS Pathogens

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

(2009) Till Strowig et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen Presentation

(2009) D. Horst et al.   JOURNAL OF IMMUNOLOGY

T Cell–Mediated Control of Epstein‐Barr Virus Infection in Humanized Mice

(2009) Misako Yajima et al.   JOURNAL OF INFECTIOUS DISEASES

The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation

(2009) Jianmin Zuo et al.   PLoS Pathogens

Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle

(2009) Nathan P. Croft et al.   PLoS Pathogens

A New Humanized Mouse Model of Epstein‐Barr Virus Infection That Reproduces Persistent Infection, Lymphoproliferative Disorder, and Cell‐Mediated and Humoral Immune Responses

(2008) Misako Yajima et al.   JOURNAL OF INFECTIOUS DISEASES

Epstein-Barr Virus LF2: an Antagonist to Type I Interferon

(2008) L. Wu et al.   JOURNAL OF VIROLOGY

Epstein-Barr Virus BGLF4 Kinase Suppresses the Interferon Regulatory Factor 3 Signaling Pathway

(2008) J.-T. Wang et al.   JOURNAL OF VIROLOGY